Compositions and methods for epigenetic regulation of HBV gene expression
US12390538B2 · kind B2 · utility
0Cited by
105References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 2, 2024 |
| Grant date | Aug 19, 2025 |
| Priority date | — |
| Expiry date | Jul 2, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to compositions, methods, strategies, and treatment modalities related to the epigenetic modification of hepatitis B virus (HBV) genes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.